Stockreport

Stoke Therapeutics shares data from Phase 1/2a trial for STK-001 in Dravet syndrome [Seeking Alpha]

Stoke Therapeutics, Inc.  (STOK) 
Last stoke therapeutics, inc. earnings: 11/12 08:00 am Check Earnings Report
PDF Stoke Therapeutics shares data from Phase 1/2a trial for STK-001 in Dravet syndrome [Read more]